Patents by Inventor Paul Nigel Wray

Paul Nigel Wray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
    Publication number: 20040180937
    Abstract: A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.
    Type: Application
    Filed: March 24, 2004
    Publication date: September 16, 2004
    Applicants: SmithKline Beecham, plc, SmithKline Beecham Corporation
    Inventors: Jeffrey Roger Granett, Hamish Ross, Jaikrishna Patel, Robin Kevin John Price, Paul Nigel Wray
  • Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione
    Publication number: 20040082621
    Abstract: A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.
    Type: Application
    Filed: November 19, 2003
    Publication date: April 29, 2004
    Applicants: SmithKline Beecham p.l.c., SmithKline Beecham Corporation
    Inventors: Jeffrey Roger Granett, Hamish Ross, Jaikrishna Patel, Robin Kevin John Price, Paul Nigel Wray
  • Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
    Publication number: 20030187030
    Abstract: A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.
    Type: Application
    Filed: March 21, 2003
    Publication date: October 2, 2003
    Applicants: SmithKline Beecham plc, Smith Kline Beecham Corporation
    Inventors: Jeffrey Roger Granett, Hamish Ross, Jaikrishna Patel, Robin Kevin John Price, Paul Nigel Wray
  • Composition comprising 5-[4-[2-(N-methyl-N-2-pyridy)amino)ethoxy]benzyl]thiazolidine-2,4-dione
    Publication number: 20020177612
    Abstract: A pharmaceutical composition comprising Compound (1), characterised in that the composition comprises 2 to 12 mg of Compound (1) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.
    Type: Application
    Filed: February 5, 2002
    Publication date: November 28, 2002
    Applicant: SmithKline Beecham p.I.c.
    Inventors: Jeffrey Roger Granett, Hamish Ross, Jaikrishna Patel, Robin Kevin John Price, Paul Nigel Wray